Eli Glezer
Founder presso SINGULAR GENOMICS SYSTEMS, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Dr. Eli Glezer is a Chief Scientific Officer at Singular Genomics Systems, Inc. Dr. Glezer was previously employed as a Chief Technology Officer by Meso Scale Diagnostics LLC.
He received his undergraduate degree from the University of California, Berkeley and a doctorate degree from Harvard University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
15/03/2024 | 4 585 000 ( 6.20% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Eli Glezer
Società | Posizione | Inizio |
---|---|---|
SINGULAR GENOMICS SYSTEMS, INC. | Founder | 01/06/2016 |
Precedenti posizioni note di Eli Glezer
Società | Posizione | Fine |
---|---|---|
Meso Scale Diagnostics LLC
Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Meso Scale Diagnostics LLC develops and markets solutions for multiplex biological assays. Its products include angiogenesis and vascular, bone metabolism, cytokine and chemokine, inflammation, intracellular signaling, neurodegeneration, toxicology, and immuno assay kits. The firms services include assay development, custom conjugation, prototype printing, instrument services and warranties. The company was founded in 1995 and is headquartered in Rockville, MD. | Chief Tech/Sci/R&D Officer | 01/01/2016 |
Formazione di Eli Glezer
Harvard University | Doctorate Degree |
University of California, Berkeley | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SINGULAR GENOMICS SYSTEMS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Meso Scale Diagnostics LLC
Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Meso Scale Diagnostics LLC develops and markets solutions for multiplex biological assays. Its products include angiogenesis and vascular, bone metabolism, cytokine and chemokine, inflammation, intracellular signaling, neurodegeneration, toxicology, and immuno assay kits. The firms services include assay development, custom conjugation, prototype printing, instrument services and warranties. The company was founded in 1995 and is headquartered in Rockville, MD. | Health Technology |
- Borsa valori
- Insiders
- Eli Glezer